Milestone Pharmaceuticals... (MIST)

NASDAQ: MIST · Real-Time Price · USD

1.30

-0.02 (-1.52%)

At close: May 02, 2025, 3:59 PM

1.31

0.77%

After-hours: May 02, 2025, 04:25 PM EDT

Milestone Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-41.52M	-59.69M	-58.39M	-42.85M	-49.97M	-55.23M	-23.18M	-8.09M
Depreciation & Amortization	105K	92K	89K	93K	97K	38K	10K	8K
Stock-Based Compensation	5.78M	9.53M	9.05M	7.28M	4.95M	1.19M	633K	190K
Other Working Capital	1.32M	1.24M	-2.35M	1.62M	-3.72M	-672K	-1.38M	58K
Other Non-Cash Items	3.13M	2.39M	44K	7.27M	5.53M	1.63M	787K	59K
Deferred Income Tax	n/a	n/a	n/a	-7.27M	-5.53M	-1.63M	n/a	n/a
Change in Working Capital	3.66M	1.24M	-3.26M	2.26M	-5.81M	2.85M	1.5M	-164K
Operating Cash Flow	-28.85M	-46.42M	-52.47M	-33.22M	-50.73M	-51.15M	-21.05M	-8.05M
Capital Expenditures	-33K	-112K	-272K	n/a	n/a	-413K	-5K	-36K
Cash Acquisitions	n/a	n/a	86.12M	n/a	n/a	35.41M	n/a	n/a
Purchase of Investments	n/a	-137.13M	-85.85M	-15M	-90M	-35M	-3.03M	-16.03M
Sales Maturities Of Investments	121.87M	142M	29M	85M	20M	35.03M	19.03M	45K
Other Investing Acitivies	-113.59M	n/a	-86.12M	70M	-70M	-35.41M	16M	-15.99M
Investing Cash Flow	8.28M	4.76M	-57.12M	70M	-70M	-384K	16M	-16.02M
Debt Repayment	n/a	50M	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.86M	-2.21M	458K	5.05M	48.31M	44K	461K	-278K
Financial Cash Flow	32.12M	47.79M	3.09M	5.05M	73.22M	85.41M	80.11M	30.72M
Net Cash Flow	11.55M	6.12M	-106.5M	41.83M	-47.51M	33.87M	75.07M	6.65M
Free Cash Flow	-28.88M	-46.54M	-52.74M	-33.22M	-50.73M	-51.56M	-21.05M	-8.09M